Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Texas Business Times.
Press releases published on April 25, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bitfarms Ltd. - BITF
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bitfarms Ltd. (“Bitfarms” or the “Company”) (NASDAQ: BITF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646- …

Top Technology Executives Recognized at the 2025 HoustonCIO ORBIE Awards
Leading CIOs honored for leadership, innovation, and business impact. HOUSTON, April 25, 2025 (GLOBE NEWSWIRE) -- The 2025 HoustonCIO ORBIE Awards recognized the exceptional leadership and innovation of top technology executives from Chevron, NOV, Nabors, …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of KinderCare Learning Companies, Inc. - KLC
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of KinderCare Learning Companies, Inc. (“KinderCare” or the “Company”) (NYSE: KLC). Such investors are advised to contact Danielle Peyton at …

Joseph Schnaier Launches $1,000 National Scholarship to Support and Cultivate Future Finance Leaders in U.S. Undergraduate Programs
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- The Joseph Schnaier Scholarship for Finance Students is now open for applications from undergraduate students pursuing finance-related degrees across accredited institutions in the United States. This …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pony AI Inc. - PONY
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Pony AI Inc. (“Pony” or the “Company”) (NASDAQ: PONY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581- …

HPQ Silicium : Correction de communiqués antérieurs
En réponse à une demande formulée par l’Autorité des marchés financiers, HPQ Silicium procède à la publication d’un communiqué rectificatif visant à corriger certaines informations à caractère prospectif diffusées dans des communiqués antérieurs. MONTRÉAL, …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. (“Nyxoah” or the “Company”) (NASDAQ: NYXH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581- …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Vita Coco Company, Inc. - COCO
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Vita Coco Company, Inc. (“Vita Coco” or the “Company”) (NASDAQ: COCO). Such investors are advised to contact Danielle Peyton at newaction@ …

Willms and Associates Named Rockford Mutual 2024 Agency of the Year
Rockford, Illinois, April 25, 2025 (GLOBE NEWSWIRE) -- ROCKFORD, Illinois – The Willms …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of 3D Systems Corporation - DDD
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of 3D Systems Corporation (“3D Systems” or the “Company”) (NYSE: DDD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Endeavour Silver Corp. - EXK
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Adverum Biotechnologies, Inc. (“Adverum” or the “Company”) (NASDAQ: ADVM). Such investors are advised to contact Danielle Peyton at newaction@ …

Starton Therapeutics Presents Positive Data from Phase 1b Study Evaluating STAR-LLD for the Treatment of Relapsed/Refractory Multiple Myeloma at the American Association for Cancer Research (AACR) Annual Meeting 2025
PARAMUS, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary dermal technologies, announced today the presentation of positive data …

IMA360 Achieves 112% Revenue Growth and Expands Partnerships with McKesson and BRP
IRVING, TX, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- IMA360, a Texas-based provider of cloud-native profit optimization solutions, is pleased to announce it has recorded a 112% revenue growth in its 2024 fiscal year, in addition to acquiring …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Northrop Grumman Corporation – NOC
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Northrop Grumman Corporation (“Northrop Grumman” or the “Company”) (NYSE: NOC). Such investors are advised to contact Danielle Peyton at newaction@ …

Harbinger Health Unveils Promising New Data on Early Cancer Detection Platform at AACR 2025
Novel analytical framework establishes a clinically meaningful performance assessment of blood-based early detection tests Innovative methodology enhances cancer signal detection, boosts specificity and predictive value Presentations further validate the …

DTE Completes Construction on Pine River Solar Park
Detroit, April 25, 2025 (GLOBE NEWSWIRE) -- DTE Energy (NYSE:DTE), Michigan’s largest producer of and investor in renewable energy, announced that construction has been completed at Pine River Solar Park during a ribbon-cutting ceremony at the site today. …

Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting
Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms Novel T cell engager ZW209 demonstrates durable activity in small cell lung cancer; IND submission expected in 1H-2026 VANCOUVER, British Columbia, April …

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
BDC-3042 was well tolerated up to 10 mg/kg q2w with no dose-limiting toxicities and no drug-related serious adverse events BDC-3042 showed biological activity, with clear dose-dependent increases in proinflammatory cytokines and chemokines BDC-3042 showed …

Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025
Activity in preclinical models of ovarian, prostate, and non-small cell lung cancer supports potential utility of OP-3136, a KAT6 inhibitor, in indications beyond breast cancer Patient recruitment ongoing in Phase 1 trial of OP-3136 as a monotherapy and in …